These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9002937)

  • 1. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
    Arepally G; McKenzie SE; Jiang XM; Poncz M; Cines DB
    Blood; 1997 Jan; 89(2):370-5. PubMed ID: 9002937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
    Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
    J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
    Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
    Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
    Rollin J; Pouplard C; Sung HC; Leroux D; Saada A; Gouilleux-Gruart V; Thibault G; Gruel Y
    Blood; 2015 Apr; 125(15):2397-404. PubMed ID: 25680756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A naturally occurring mutation in Fc gamma RIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor.
    Norris CF; Pricop L; Millard SS; Taylor SM; Surrey S; Schwartz E; Salmon JE; McKenzie SE
    Blood; 1998 Jan; 91(2):656-62. PubMed ID: 9427722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients.
    Bazilio AP; Viana VS; Toledo R; Woronik V; Bonfá E; Monteiro RC
    Nephrol Dial Transplant; 2004 Jun; 19(6):1427-31. PubMed ID: 15004265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.
    Sanders LA; Feldman RG; Voorhorst-Ogink MM; de Haas M; Rijkers GT; Capel PJ; Zegers BJ; van de Winkel JG
    Infect Immun; 1995 Jan; 63(1):73-81. PubMed ID: 7806386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor.
    Taylor SM; Reilly MP; Schreiber AD; Chien P; Tuckosh JR; McKenzie SE
    Blood; 2000 Dec; 96(13):4254-60. PubMed ID: 11110699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
    Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
    Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.
    Palomo I; Pereira J; Alarcón M; Díaz G; Hidalgo P; Pizarro I; Jara E; Rojas P; Quiroga G; Moore-Carrasco R
    J Clin Lab Anal; 2005; 19(5):189-95. PubMed ID: 16170812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia.
    Brandt JT; Isenhart CE; Osborne JM; Ahmed A; Anderson CL
    Thromb Haemost; 1995 Dec; 74(6):1564-72. PubMed ID: 8772238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia.
    Gerotziafas GT; Elalamy I; Lecrubier C; Lebrazi J; Mirshahi M; Potevin F; Lecompte T; Samama MM
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):511-20. PubMed ID: 11685038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the humoral immune response in heparin-induced thrombocytopenia.
    Suh JS; Malik MI; Aster RH; Visentin GP
    Am J Hematol; 1997 Mar; 54(3):196-201. PubMed ID: 9067497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The homozygous FcgammaRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes.
    Gruel Y; Pouplard C; Lasne D; Magdelaine-Beuzelin C; Charroing C; Watier H
    Blood; 2004 Nov; 104(9):2791-3. PubMed ID: 15191947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
    Rollin J; Pouplard C; Gruel Y
    Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections.
    Sanders LA; van de Winkel JG; Rijkers GT; Voorhorst-Ogink MM; de Haas M; Capel PJ; Zegers BJ
    J Infect Dis; 1994 Oct; 170(4):854-61. PubMed ID: 7930727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
    Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
    Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.